iBio, Inc.
- IBIO
- NASDAQ
- Biotechnology
- CDMO/Bioprocessing
- Biotech Contract Development
$0.77
Today −2.11%Quote Oct 16, 2026, 08:00 PM UTC
−38.70%over the last month
Max drawdown −42.4%From 1-month high −42.4%3 months −44.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$49.3M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$5.00
+552.5% from here
Floor
$0.75
1.8% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about IBIOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q3 2022 revenue $1.9M
- Ibio Inc$1.8M92.6%
- Ibio Cdmo$143,0007.4%
Industry
Biotechnology
Employees
23